Molecular subtyping of tumors from patients with familial glioma

Vanessa Y. Ruiz, Corinne E. Praska, Georgina Armstrong, Thomas M. Kollmeyer, Seiji Yamada, Paul A. Decker, Matthew L. Kosel, Jeanette E. Eckel-Passow, Daniel H. Lachance, Matthew N. Bainbridge, Beatrice S. Melin, Melissa L. Bondy, Robert B. Jenkins

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Background Single-gene mutation syndromes account for some familial glioma (FG); however, they make up only a small fraction of glioma families. Gliomas can be classified into 3 major molecular subtypes based on isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion. We hypothesized that the prevalence of molecular subtypes might differ in familial versus sporadic gliomas and that tumors in the same family should have the same molecular subtype. Methods Participants in the FG study (Gliogene) provided samples for germline DNA analysis. Formalin-fixed, paraffin-embedded tumors were obtained from a subset of FG cases, and DNA was extracted. We analyzed tissue from 75 families, including 10 families containing a second affected family member. Copy number variation data were obtained using a first-generation Affymetrix molecular inversion probe (MIP) array. Results Samples from 62 of 75 (83%) FG cases could be classified into the 3 subtypes. The prevalence of the molecular subtypes was: 30 (48%) IDH-wildtype, 21 (34%) IDH-mutant non-codeleted, and 11 (19%) IDH-mutant and 1p/19q codeleted. This distribution of molecular subtypes was not statistically different from that of sporadic gliomas (P = 0.54). Of 10 paired FG samples, molecular subtypes were concordant for 7 (κ = 0.59): 3 IDH-mutant non-codeleted, 2 IDH-wildtype, and 2 IDH-mutant and 1p/19q codeleted gliomas. Conclusions Our data suggest that within individual families, patients develop gliomas of the same molecular subtype. However, we did not observe differences in the prevalence of the molecular subtypes in FG compared with sporadic gliomas. These observations provide further insight into the distribution of molecular subtypes in FG.

Original languageEnglish (US)
Pages (from-to)810-817
Number of pages8
JournalNeuro-oncology
Volume20
Issue number6
DOIs
StatePublished - May 18 2018

Keywords

  • IDH -mutant and 1p/19q-codeleted
  • IDH -mutant non-codeleted
  • IDH -wild type
  • familial glioma (FG)
  • molecular inversion probe (MIP)

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Fingerprint Dive into the research topics of 'Molecular subtyping of tumors from patients with familial glioma'. Together they form a unique fingerprint.

  • Cite this

    Ruiz, V. Y., Praska, C. E., Armstrong, G., Kollmeyer, T. M., Yamada, S., Decker, P. A., Kosel, M. L., Eckel-Passow, J. E., Lachance, D. H., Bainbridge, M. N., Melin, B. S., Bondy, M. L., & Jenkins, R. B. (2018). Molecular subtyping of tumors from patients with familial glioma. Neuro-oncology, 20(6), 810-817. https://doi.org/10.1093/neuonc/nox192